Positive trials of cystic fibrosis treatment

Israel’s BiomX (see here previously) has reported positive initial results from its clinical trials of BX004. The treatment relieves chronic pulmonary infections in patients with cystic fibrosis. BiomX now plans to initiate a larger Phase 2/3 trial.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *